课题基金 / 基金详情

Role of Vitamin D hydroxylase on Bone Metabolism.

Role of Vitamin D hydroxylase on Bone Metabolism.
维生素 D 羟化酶对骨代谢的作用。
批准号:
12470392
负责人:
SHINKI Toshimasa
金额:
$9.41万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (B)
财政年份:
2000
资助国家:
日本
项目状态:
已结题
起止时间:
2000 至 2001

项目摘要

项目成果

SHINKI Toshimasa的其他基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Vitamin D is a steroid hormone that plays an important role in the maintenance of calcium and mineral metabolism. The 24-hydroxylase (CYP24) enzyme is a cytochrome P450 molecule that is distributed in the target tissues of vitamin D, and is induced specially by 1α, 25 dihydroxyvitamin D_3.Two functions of this enzyme have been revealed so far. One is production of 24, 25 dihydroxyvitamin D_3 from 25-hydroxyvitamin D_3 as a substrate. 24, 25-dihydroxyvitamin D_3 is known to have an effect on bone mass increments when high doses to rats. The other function of CYP24 is to inactivate 1α, 25 dihydroxyvitamin D_3 which strongly induces this enzyme, and to maintain vitamin D homeostasis. In order to clarify the physiological role of CYP24 in vivo, we have over expressed CYP24 in rats. In the present study we examined the mechanism for the alteration in serum vitamin D metabolites levels and analysed the consequent influences on bone metabolism. In CYP24 transgenic rat, we found Out that excessive alubuminures developed from early stages, and as albumin has an ability to bind megalin, a receptor for vitamin D-binding protein. The excretion of 25-hydroxyvitamin D3 in Tg rats increased as albumin excretion increased, and both parameters had a strong positive correlation. Finally we examined the influence of renal dysfunction on bone metabolism. There was a significant decrease in bone mineral density of Tg rats at 8 weeks of age when the serum parathyroid hormone level begins to rise. Infusion of 25-hydroxyvitamin D3 greatly increased the BMD in the tibia of Tg rats. The mechanisms of CYP24 overexpression for induction of nephritis need to be elucidated in future studies.
期刊论文(38)
专著(0)
科研奖励(0)
会议论文
新木 敏正: "25-ヒドロキシビタミンD_3-1α-水酸化酵素の発現調節について"日本臨床. (製本中). (2002)
Toshimasa Araki:“25-羟基维生素 D_3-1α-羟化酶的表达调节”日本临床研究(书籍正在出版)。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
細金直文, 新木敏正: "新・分子骨代謝学と骨粗鬆症"メディカルレビュー社. 513 (2001)
Naofumi Hosogane、Toshimasa Araki:“新分子骨代谢与骨质疏松症”医学评论出版 513(2001)。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Itoh, K., et al.: "Importance of membrane-or matrix-associated forms of m-CSF and RANKL/ODF in osteoclastogenesis by SaOS-4/3 cells expressing recombinant PTH/PTHrP receptors"J.Bone Miner.Res. 15・9. 1766-1775 (2000)
Itoh, K. 等人:“m-CSF 和 RANKL/ODF 的膜或基质相关形式在表达重组 PTH/PTHrP 受体的 SaOS-4/3 细胞破骨细胞生成中的重要性”J.Bone Miner.Res。 15・9。1766-1775(2000)
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Masuno, H. et al.: "Rational Design, Synthesis and Biological Activity of Novel Conformationa11y Restricted Vitamin D Analogs, (22R)-and (22S)-22-Ethyl-1,25-dihydroxy-23,24-didehydro-24a,24b-dihomo-20-epivitamin D_3"J.Med.Chem.. 45(in press). (2002)
Masuno, H. 等人:“新型构象限制性维生素 D 类似物 (22R)-和 (22S)-22-乙基-1,25-二羟基-23,24-二脱氢-24a 的合理设计、合成和生物活性
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
18
    Evidence base treatment of renal osteodistropy
    • 批准号:
      17590066
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $2.3万
    • 财政年份:
      2005
    • 负责人:
      SHINKI Toshimasa
    • 依托单位:
    Mechanisms of bone resorption in alveolar bone of IL-1 transgenic mice
    Mechanism of regulation of vitamin D metabolism at molecular level.
    • 批准号:
      08457494
    • 项目类别:
      Grant-in-Aid for Scientific Research (B)
    • 资助金额:
      $4.93万
    • 财政年份:
      1996
    • 负责人:
      SHINKI Toshimasa
    • 依托单位:
    Role of vitamin D and parathyroid hormone on vitamin D metabolism in the kidney.
    • 批准号:
      06454527
    • 项目类别:
      Grant-in-Aid for General Scientific Research (B)
    • 资助金额:
      $4.48万
    • 财政年份:
      1994
    • 负责人:
      SHINKI Toshimasa
    • 依托单位: